Use of a negative selectable marker for rapid selection of recombinant vaccinia virus

BioTechniques

Volumn 50, Issue 5, 2011, Pages 303-309

  White, Stacy D ^a   Conwell, Kip ^a   Langland, Jeffrey O ^a,b   Jacobs, Bertram L ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Southwest College Naturopathic Med   (United States)

Author keywords

Coumermycin; E3l; Gyrase pkr; Recombinant; Selection; Vaccinia virus

Indexed keywords

COUMAMYCIN; HYBRID PROTEIN; INITIATION FACTOR 2ALPHA; INTERFERON; MARKER;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVE SITE; ESCHERICHIA COLI; HOMOLOGOUS RECOMBINATION; HOST RANGE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TRANSLATION INITIATION; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS REPLICATION;

AMINOCOUMARINS; ANIMALS; CELL LINE; CRICETINAE; DIMERIZATION; ESCHERICHIA COLI; EUKARYOTIC INITIATION FACTOR-2; GENETIC VECTORS; HOST SPECIFICITY; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; VACCINIA VIRUS; VIRUS REPLICATION;

ESCHERICHIA COLI; VACCINIA VIRUS;

EID: 79957754104     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000113667     Document Type: Article

References (19)

1. Falkner, F.G. and B. Moss. 1990. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:3108-3111.
2. Ball, L.A. 1987. High-frequency homol-ogou s recombination in vaccin ia vi rus DNA. J. Virol. 61:1788-1795.
3. Mackett, M., G.L. Smith, and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:857-864.
4. Weir, J.P., G. Bajszar, and B. Moss. 1982. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA. Proc. Natl. Acad. Sci. USA 79:1210-1214.
5. Holzer, G.W., W. Gritschenberger, J.A. Mayrhofer, V. Wieser, F. Dorner, and F.G. Falkner. 1998. Dominant host range selection of vaccinia recombinants by rescue of an essential gene. Virology 249:160-166.
6. Perkus, M.E., K. Limbach, and E. Paoletti. 1989. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:3829-3836.
7. Staib, C, I. Drexler, M. Ohlmann, S. Winter-sperger, V. Erfe, and G. Sutter. 2000. Transient host range selection for genetic engineering of modifed vaccinia virus Ankara. BioTech-niques 28:1137-1148.
8. Franke, C.A., CM. Rice, J.H. Strauss, and D.E. Hruby. 1985. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Mol. Cell. Biol. 5:1918-1924.
9. Ung, T.L., C. Cao, J. Lu, K. Ozato, and T.E. Dever. 2001. Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20:3728-3737.
10. Ali, J.A., A. P. Jackson, A.J. Howells, and A. Maxwell. 1993. The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 32:2717-2724.
11. Clemens, M.J. 1997. PKR--a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29:945-949.
12. Hershey, J.W. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60:717-755.
13. Jacobs, B.L., J.O. Langland, and T. Brandt. 1998. Characterization of viral double-stranded RNA-binding proteins. Methods 15:225-232.
14. Kibler, K. V., T. Shors, K.B. Perkins, C.C. Zeman, M. P. Banaszak, J. Biesterfeldt, J.O. Langland, and B.L. Jacobs. 1997. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1992-2003.
15. Friedrich, I., M. Eizenbach, J. Sajman, H. Ben-Bassat, and A. Levitzki. 2005. A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells. Mol. Ter. 12:969-975.
16. Langland, J.O. and B.L. Jacobs. 2004. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology 324:419-429.
17. Zhou, J., L. Crawford, X.Y. Sun, and I.H. Frazer. 1991. The hygromycin-resistance-encoding gene as a selection marker for vaccinia virus recombinants. Gene 107:307-312.
18. Sanchez-Puig, J.M. and R. Blasco. 2000. Puromycin resistance (pac) gene as a selectable marker in vaccinia virus. Gene 257:57-65.
19. Wong, Y.C., L.C. Lin, C.R. Melo-Silva, S.A. Smith, and D.C. Tscharke. 2011. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection. J. Virol. Methods 171:295-298.